Author

Theresa Kungl

Leipzig University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

Klaus‐Armin NaveiD· 2 shared Robert FledrichiD· 2 shared Alexander FlügeliD· 1 shared Alonso Barrantes‐FreeriD· 1 shared Christine StadelmanniD· 1 shared Christoph WredeiD· 1 shared Daniel S. ReichiD· 1 shared David EwersiD· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Klaus‐Armin NaveORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceNature NeurosciencePeer-reviewedJun 29, 2023

Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease

Erik Schäffner, Mar Bosch-Queralt, Julia M. Edgar…·Ruth Martha Stassart

The paper challenges the view that axonal degeneration in MS results from immune-mediated damage by proposing that myelin itself increases axonal degeneration risk under inflammatory conditions.

101 citationstop 1%

mousehuman

𝕏 PostBluesky

NeurosciencebioRxivPreprintNov 8, 2021

Inversely proportional myelin growth due to altered Pmp22 gene dosage identifies PI3K/Akt/mTOR signaling as a novel therapeutic target in HNPP

Doris Krauter, David Ewers, Timon J Hartmann…·Michael Werner Sereda

This study identifies PI3K/Akt/mTOR signaling as a therapeutic target for HNPP by showing that mTOR inhibitors reduce hypermyelination in HNPP mouse models.

2 citations

mousebulk RNA-seq

𝕏 PostBluesky